KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Receivables (2016 - 2025)

Historic Receivables for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $1.3 billion.

  • Biogen's Receivables fell 444.19% to $1.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 billion, marking a year-over-year decrease of 444.19%. This contributed to the annual value of $1.3 billion for FY2025, which is 444.19% down from last year.
  • As of Q4 2025, Biogen's Receivables stood at $1.3 billion, which was down 444.19% from $1.4 billion recorded in Q3 2025.
  • Biogen's Receivables' 5-year high stood at $2.0 billion during Q1 2022, with a 5-year trough of $7.0 million in Q2 2023.
  • For the 5-year period, Biogen's Receivables averaged around $1.5 billion, with its median value being $1.7 billion (2023).
  • Per our database at Business Quant, Biogen's Receivables crashed by 9961.5% in 2023 and then skyrocketed by 2314428.57% in 2024.
  • Quarter analysis of 5 years shows Biogen's Receivables stood at $1.8 billion in 2021, then fell by 6.97% to $1.7 billion in 2022, then fell by 2.51% to $1.7 billion in 2023, then decreased by 15.58% to $1.4 billion in 2024, then dropped by 4.44% to $1.3 billion in 2025.
  • Its Receivables stands at $1.3 billion for Q4 2025, versus $1.4 billion for Q3 2025 and $1.6 billion for Q2 2025.